Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Marc Peter Bonaca

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bonaca, Marc

Item TypeName
Concept Treatment Outcome
Academic Article Comparative Efficacy of Endovascular Revascularization Versus Supervised Exercise Training in Patients With Intermittent Claudication: Meta-Analysis of Randomized Controlled Trials.
Academic Article Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).
Academic Article Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2?P-TIMI 50).
Academic Article Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.
Academic Article Peripheral Revascularization in Patients With?Peripheral Artery Disease With?Vorapaxar: Insights From the TRA 2?P-TIMI 50 Trial.
Academic Article Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial.
Academic Article Prasugrel Versus Ticagrelor: Uncertainty Remains.
Academic Article Efficacy and safety of vorapaxar as approved for clinical use in the United States.
Academic Article Efficacy and safety of vorapaxar in patients with prior ischemic stroke.
Academic Article Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50.
Academic Article Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.
Academic Article Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2?P-TIMI 50.
Academic Article Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2?P-TIMI 50 trial.
Academic Article Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.
Academic Article Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
Academic Article Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
Academic Article Patterns of long-term thienopyridine therapy and outcomes in patients with acute coronary syndrome treated with coronary stenting: Observations from the TIMI-38 Coronary Stent Registry.
Academic Article Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Academic Article Pharmacological treatment and current management of peripheral artery disease.
Academic Article Efficacy and Safety of Ticagrelor Over?Time in Patients With Prior MI in?PEGASUS-TIMI 54.
Academic Article Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
Academic Article New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 ?P-TIMI 50 trial.
Academic Article Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22.
Academic Article Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.
Academic Article Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial.
Academic Article The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial.
Academic Article Antithrombotic Therapy in Patients With Peripheral Artery Disease.
Academic Article Potent P2Y12 Inhibitors in Men?Versus?Women: A?Collaborative?Meta-Analysis?of?Randomized?Trials.
Academic Article Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2?P-TIMI 50).
Academic Article Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
Academic Article Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registry.
Academic Article Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial).
Academic Article Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients.
Academic Article Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function.
Academic Article Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.
Academic Article Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2?P-TIMI 50 trial.
Academic Article Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Academic Article Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
Academic Article Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries.
Academic Article Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54.
Academic Article Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
Academic Article Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
Academic Article Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD.
Academic Article Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2?P-TIMI 50 trial.
Academic Article The Pathobiology of Acute Limb Ischemic?Events and Stent Failure in Peripheral Artery Disease: A Step in the Right Direction.
Academic Article The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism.
Academic Article No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials.
Academic Article Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Academic Article Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Academic Article Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review.
Academic Article Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease.
Academic Article Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
Academic Article Long-term safety of drug-coated devices for peripheral revascularisation.
Academic Article Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization.
Academic Article Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.
Academic Article Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD?Trial.
Academic Article Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial.
Academic Article Diabetes Mellitus and Risk Stratification After Peripheral Artery Revascularization.
Academic Article Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease.
Academic Article Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease Among Medicare Beneficiaries Between 2017 and 2018: Participation Rates and Outcomes.
Academic Article Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.
Academic Article Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Academic Article Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 Trial.
Academic Article Extended dual antiplatelet therapy with ticagrelor 60?mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study.
Academic Article Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes.
Academic Article Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial.
Academic Article Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD.
Academic Article Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
Academic Article Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD.
Academic Article Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2?P-TIMI 50 trial.
Academic Article Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.
Academic Article Tradeoffs in Approach to PAD?Revascularization: Shared Decision Making in the Spotlight.
Academic Article Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
Academic Article Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes.
Academic Article Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
Academic Article Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes.
Academic Article Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
Academic Article Guideline-Directed Medical Therapy in?PAD: Time to Step on the Gas.
Academic Article Effects of Elective Coronary Revascularization vs Medical Therapy Alone on Noncardiac Mortality: A Meta-Analysis.
Academic Article Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease.
Academic Article Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials.
Academic Article Disparities in Diagnosis, Treatment, and?Outcomes of Peripheral Artery?Disease: JACC Scientific Statement.
Academic Article Recapturing the Team Approach to Vascular Care.

Search Criteria
  • Rehabilitation Outcome

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)